R&D introduction

CER Biotech is composed of technological platforms possessing expertise in the fields of immunology, infectious diseases, molecular biology, cell culture and animal housing. These competences enable it to collaborate in research programmes of the pharmaceutical industry and biotechnology companies. CER Biotech also develops partnerships with academic research units and public institutions. Its main areas of research include obtaining, characterising and producing murine and human monoclonal antibodies, antibody engineering and the development of diagnostic reagents. Housing infrastructure enables it to develop animal models in call therapy, infectiology and cancerology.


Contact us